Science Committee

IGBA (formerly IGPA) was initially founded to be able to participate as an Interested Party at the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). This forum brings together the regulatory authorities and the pharmaceutical industries of the European Union, Japan and the USA to discuss scientific and technical aspects of drug registration and develop scientific guidelines. The aim is to achieve greater harmonization and convergence between the various regions so that  high quality, safe and efficacious medicines can be developed and registered in the most resource-efficient manner. The IGBA Science Committee’s main activity rotates consequently around the bi-annual ICH meetings. It nominates experts from the generic medicines industry to those Expert Working Groups (EWGs) which are relevant for our industry sector.

Industry experts also participate on an ad-hoc basis in the following WHO activities, programmes and issues:

  • Prequalification Programme
  • Specification for pharmaceutical preparations
  • Paediatrics guideline
  • Essential medicines list
  • Generics guideline
  • INN Programme
  • Biological Standardizations
  • Similar biotherapeutics guideline


Share this page!

Contact Info


Rue de Cornavin 11
1201 Geneva, Switzerland

This email address is being protected from spambots. You need JavaScript enabled to view it.  
Secretary General –   This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on: Twitter - LinkedIn - YouTube

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site